Toggle navigation
Admin
Home
Manager
Categories
Categories Import
Create User
Domain
Domain Import
Search
Webpage
CSV File Import
Dropdown Items
Stage
Icons
Add missing lang
Wordsstock
Feedbacks
Translation
Login
Home
Domains
51109
Update
Update Domain: 51109
Live
Domain
Keyword
Name
Short Desc
Long Desc
Industry
Cat1
Cat2
Site Language
en-gb,
Wiki
Wikidata
Search Count
Webpage Count
Social Count
Total Count
Subdomain Count
Webpage Count Ordered
Fi Count
Fin Name
AstraZeneca PLC
Fin Industry
Drug Manufacturers—General
Fin Sector
Healthcare
Fin Desc
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Name2
Market
Ticker
Subdomain Load
Status Code
200
Status
OK
Redir Url
Site Adult Words
0
Folder Count
Icon
https://twitter.com/i/user/%s
https://www.facebook.com/%s
Linkedin
Report Date
Requires Update
Hide
Site Title
Site Meta Description
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Site Meta Keywords
Alexa
Site Status
Domain ID
Site Status Int
Site Emails
Site Total Pages
Site Size
Site Redirect Domain
Site Is Wordpress
0
Site Num Words Home
-1
Site Images
-1
Site Has Online Store
-1
Site Has Ssl
-1
Site Has Mx
1
Site Ip S
312777225
Site Subnet
312777216
Site Ns 1
udns1.cscdns.net
Site Ip
Content Reorder
Top Level Update
Admin Review Required
Adjust Order
Imported
Int Search
Save